Media Room

May 8, 2019

Menlo Park, CA
FARAPULSE Receives FDA Breakthrough Designation for its Endocardial Pulsed Field Ablation System

May 3, 2019

Austin, TX
BioStable Science & Engineering Surpasses 500 Patients Treated Worldwide with the HAART Devices

April 23, 2019

San Carlos, CA
BAROnova Announces FDA Approval of the TransPyloric Shuttle® (TPS®) Device

February 21, 2019

Plymouth Meeting, PA
Geneos Therapeutics Secures $10.5 Million in Series A Financing to Develop the Next Generation of Neoantigen-Targeting Cancer Immunotherapies

December 27, 2018

Santa Rosa, CA
Boston Scientific Exercises Option to Acquire Millipede, Inc. for $540M (Santé Ventures Leads Deal as Only Institutional Investor)

December 5, 2018

Houston, TX
Iterion Therapeutics Initiates Phase I Clinical Study of Tegavivint in Patients with Desmoid Tumors

November 2, 2018

Austin, TX
HNI Healthcare Acquires Martin Healthcare Group to Expand Footprint

November 2, 2018

New York, NY
CRG Provides $65 Million Commitment, Positioning HNI Healthcare for Transformation

September 25, 2018

Austin, TX
Molecular Templates, Inc. Announces Closing of Public Offering of Common Stock and the Full Exercise of the Underwriters’ Option to Purchase Additional Shares

September 19, 2018

Austin, TX
Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy

July 20, 2018

Marlborough, MA
Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

July 9, 2018

Franklin Lakes, NJ
BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease

March 30, 2018

Northwestern Memorial Hospital Surgeon First in Illinois to Repair Aortic Valve with Novel Ring

January 24, 2018

Marlborough, MA
Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.

January 22, 2018

San Francisco, CA
Lyric Pharma Granted FDA Fast Track Designation for Lead Product Ulimorelin for Enteral Feeding Intolerance (EFI)